Viscosupplementation Devices - Medical Devices Pipeline Assessment, 2017

  • ID: 4307867
  • Report
  • 80 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Ampio Pharmaceuticals Inc
  • BioTime Inc
  • Carticept Medical, Inc.
  • Cocoon Biotech, Inc.
  • Flex Biomedical Inc
  • OPKO Health Inc
  • MORE
Viscosupplementation Devices - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Viscosupplementation Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Viscosupplementation Device currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Viscosupplementation Device pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Scope

- Extensive coverage of the Viscosupplementation Device under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Viscosupplementation Device and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry

Reasons to buy

The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Viscosupplementation Device under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ampio Pharmaceuticals Inc
  • BioTime Inc
  • Carticept Medical, Inc.
  • Cocoon Biotech, Inc.
  • Flex Biomedical Inc
  • OPKO Health Inc
  • MORE
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Viscosupplementation Devices Overview
3 Products under Development
3.1 Viscosupplementation Devices - Pipeline Products by Stage of Development
3.2 Viscosupplementation Devices - Pipeline Products by Segment
3.3 Viscosupplementation Devices - Pipeline Products by Territory
3.4 Viscosupplementation Devices - Pipeline Products by Regulatory Path
3.5 Viscosupplementation Devices - Pipeline Products by Estimated Approval Date
3.6 Viscosupplementation Devices - Ongoing Clinical Trials
4 Viscosupplementation Devices - Pipeline Products under Development by Companies
4.1 Viscosupplementation Devices Companies - Pipeline Products by Stage of Development
4.2 Viscosupplementation Devices - Pipeline Products by Stage of Development
5 Viscosupplementation Devices Companies and Product Overview
5.1 Ampio Pharmaceuticals Inc Company Overview
5.1.1 Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Anika Therapeutics Inc Company Overview
5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 BioTime Inc Company Overview
5.3.1 BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Bioventus LLC Company Overview
5.4.1 Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 Carticept Medical, Inc. Company Overview
5.5.1 Carticept Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Chi2Gel Ltd. Company Overview
5.6.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cocoon Biotech, Inc. Company Overview
5.7.1 Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 DePuy Synthes Inc Company Overview
5.8.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Flex Biomedical Inc Company Overview
5.9.1 Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Hanmi Pharmaceuticals Co Ltd Company Overview
5.10.1 Hanmi Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 Kalvista Pharmaceuticals Inc Company Overview
5.11.1 Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Moebius Medical Ltd Company Overview
5.12.1 Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 OPKO Health Inc Company Overview
5.13.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.14.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 Spring Therapeutics Company Overview
5.15.1 Spring Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
5.16 Synolyne Pharma Company Overview
5.16.1 Synolyne Pharma Pipeline Products & Ongoing Clinical Trials Overview
5.17 University of Kansas Company Overview
5.17.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
6 Viscosupplementation Devices - Recent Developments
6.1 May 08, 2017: HYMOVIS: An Innovation in HA-Based Viscoelastic Hydrogel Technology in the Treatment of Osteoarthritis Knee Pain
6.2 May 05, 2017: Smith & Nephew 2017 First Quarter Trading Report
6.3 May 03, 2017: Anika Reports First Quarter 2017 Financial Results
6.4 Apr 28, 2017: Lennart Johansson to Join BONESUPPORT Board of Directors
6.5 Apr 24, 2017: Bioventus Names David Varner Vice President of Marketing, Active Healing Therapies
6.6 Apr 11, 2017: BONESUPPORT Appoints Michael Diefenbeck as Chief Medical Officer
6.7 Mar 22, 2017: HYMOVIS Demonstrates Superior Biomechanical Lubricating Properties
6.8 Mar 20, 2017: Ampio Pharmaceuticals Provides Corporate Update
6.9 Mar 16, 2017: KalVista Pharmaceuticals Reports Fiscal Third Quarter Results
6.10 Mar 09, 2017: KalVista Pharmaceuticals Appoints Dr. Andreas Maetzel Senior Vice President of Medical
6.11 Feb 27, 2017: Ampio Receives Guidance from the FDA and Proposes a Path for Approval for Single-Injection Ampion for the Treatment of Pain Due to Severe Osteoarthritis of the Knee
6.12 Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results
6.13 Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011
6.14 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results
6.15 Feb 09, 2017: Smith & Nephew: Directorate Change
6.16 Feb 08, 2017: OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis
6.17 Feb 03, 2017: SEIKAGAKU: Consolidated Financial Results for the First Nine Months of Fiscal 2016
6.18 Feb 01, 2017: Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis
6.19 Jan 17, 2017: Bioventus Selects MEDSERVICE to Distribute DUROLANE in Russia
6.20 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew
6.21 Jan 06, 2017: BONESUPPORT CEO Richard Davies to present at Medtech Showcase 2017
6.22 Dec 21, 2016: Bjorn Westberg to Join BONESUPPORT as Chief Financial Officer
6.23 Dec 20, 2016: Appointment of Nestle Skin Health CEO ad interim
6.24 Dec 19, 2016: Anika Wins CE Mark Approval For ORTHOVISC-T To Relieve Pain and Restore Function of Tendons Damaged by Chronic Injury
6.25 Dec 16, 2016: BONESUPPORT Confirms Election of Dr. Hakan Bjorklund as Chairman of the Board
6.26 Nov 30, 2016: Graham Baker appointed Chief Financial Officer
6.27 Nov 14, 2016: Bioventus Expands to Mexico with DUROLANE for Knee Osteoarthritis Patients
6.28 Nov 10, 2016: HYMOVIS Receives Permanent, Product-Specific J-Code from the Center for Medicare and Medicaid Services
6.29 Nov 08, 2016: Seikagaku Announces Exclusive Distributorship Agreement in the U.S. for VISCO-3, A Three-Injection Viscosupplement Product
6.30 Nov 07, 2016: Bioventus Appoints Andrew McCartney Managing Director, International for EMEA
6.31 Nov 07, 2016: BONESUPPORT Announces Key Corporate Appointment To Drive Growth In North America
6.32 Nov 03, 2016: Lattice Biologics Inks Strategic Partnerships With OA Centers of America, Resilience, and Cryoport
6.33 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report
6.34 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results
6.35 Aug 30, 2016: Ampio Reports Additional Peer-Reviewed Publication on Ampion
6.36 Aug 03, 2016: Ampio Updates Regulatory Status Of AMPION
6.37 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results
6.38 Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results
6.39 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017
6.40 Jul 05, 2016: Fidia Presents New Data on Hymovis, a Breakthrough in Viscoelastic Technology, at the American Orthopaedic Society for Sports Medicine 2016 Annual Meeting
6.41 Jul 01, 2016: Bioventus Extends Distribution Agreement for SUPARTZ FX
6.42 Jun 30, 2016: Ampio Announces Results of Ampion Trials
6.43 Jun 24, 2016: Michael Minogue Named to Bioventus Board of Managers
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Viscosupplementation Devices - Pipeline Products by Stage of Development
Table 2: Viscosupplementation Devices - Pipeline Products by Segment
Table 3: Viscosupplementation Devices - Pipeline Products by Territory
Table 4: Viscosupplementation Devices - Pipeline Products by Regulatory Path
Table 5: Viscosupplementation Devices - Pipeline Products by Estimated Approval Date
Table 6: Viscosupplementation Devices - Ongoing Clinical Trials
Table 7: Viscosupplementation Companies - Pipeline Products by Stage of Development
Table 8: Viscosupplementation Devices - Pipeline Products by Stage of Development
Table 9: Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Ampion - Product Status
Table 11: Ampion - Product Description
Table 12: Ampio Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 13: Ampion - A Randomized, Pre-approval Study to Evaluate the Efficacy of Ampion in Patients with Severe Knee Osteoarthritis
Table 14: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Cingal - Product Status
Table 16: Cingal - Product Description
Table 17: MONOVISC - Product Status
Table 18: MONOVISC - Product Description
Table 19: MONOVISC - Hip - Product Status
Table 20: MONOVISC - Hip - Product Description
Table 21: ORTHOVISC-T - Product Status
Table 22: ORTHOVISC-T - Product Description
Table 23: Anika Therapeutics Inc - Ongoing Clinical Trials Overview
Table 24: MONOVISC - Hip - Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip
Table 25: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 26: ReGlyde - Product Status
Table 27: ReGlyde - Product Description
Table 28: Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Supartz 3 - Product Status
Table 30: Supartz 3 - Product Description
Table 31: Carticept Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Agilus - Product Status
Table 33: Agilus - Product Description
Table 34: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Chi2Knee - Product Status
Table 36: Chi2Knee - Product Description
Table 37: Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Silk Hydrogel - Product Status
Table 39: Silk Hydrogel - Product Description
Table 40: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Platelet Rich Plasma System - Product Status
Table 42: Platelet Rich Plasma System - Product Description
Table 43: Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Flex Polymer - Product Status
Table 45: Flex Polymer - Product Description
Table 46: Hanmi Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Hyalrheuma - Product Status
Table 48: Hyalrheuma - Product Description
Table 49: Hanmi Pharmaceuticals Co Ltd - Ongoing Clinical Trials Overview
Table 50: Hyalrheuma - Phase 3 Clinical Trial for Osteoarthritis Medicine Hyalrheuma
Table 51: Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 52: ActaVisc - Product Status
Table 53: ActaVisc - Product Description
Table 54: Hydros - Product Status
Table 55: Hydros - Product Description
Table 56: Hydros TA - Product Status
Table 57: Hydros TA - Product Description
Table 58: Hydros TA - Hip - Product Status
Table 59: Hydros TA - Hip - Product Description
Table 60: Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 61: MM-II - Product Status
Table 62: MM-II - Product Description
Table 63: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Enko 1 - Product Status
Table 65: Enko 1 - Product Description
Table 66: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Thermal-Sensitive Chitosan Gel - Product Status
Table 68: Thermal-Sensitive Chitosan Gel - Product Description
Table 69: Spring Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
Table 70: CA-5136 - Product Status
Table 71: CA-5136 - Product Description
Table 72: Synolyne Pharma Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Arthrovisc - Product Status
Table 74: Arthrovisc - Product Description
Table 75: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
Table 76: 3-D Colloidal Gel - Product Status
Table 77: 3-D Colloidal Gel - Product Description
Table 78: Glossary

1.2 List of Figures
Figure 1: Viscosupplementation Devices - Pipeline Products by Stage of Development
Figure 2: Viscosupplementation Devices - Pipeline Products by Segment
Figure 3: Viscosupplementation Devices - Pipeline Products by Territory
Figure 4: Viscosupplementation Devices - Pipeline Products by Regulatory Path
Figure 5: Viscosupplementation Devices - Pipeline Products by Estimated Approval Date
Figure 6: Viscosupplementation Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ampio Pharmaceuticals Inc
  • Anika Therapeutics Inc
  • BioTime Inc
  • Bioventus LLC
  • Carticept Medical, Inc.
  • Chi2Gel Ltd.
  • Cocoon Biotech, Inc.
  • DePuy Synthes Inc
  • Flex Biomedical Inc
  • Hanmi Pharmaceuticals Co Ltd
  • Kalvista Pharmaceuticals Inc
  • Moebius Medical Ltd
  • OPKO Health Inc
  • Shanghai Haohai Biological Technology Co Ltd
  • Spring Therapeutics
  • Synolyne Pharma
  • University of Kansas
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll